FGF10 and geroderma osteodysplastica: Although therapeutic approaches using exogenous FGFs, antibodies, or small molecules are still challenging, and many avenues of the investigation remain open, this study provides the concept that therapeutic strategies aimed directly at FGF10 could be beneficial in the treatment of GO.